Drugmakers would have until 2032 to cut ties with WuXi AppTec and other Chinese life sciences companies, according to an ...

Bernie Sanders (I-VT) and Jeff Merkley (D-OR) accused a new US Chamber of Commerce coalition of attempting to “stymie the ...

Bluebird bio’s stock $BLUE jumped over 20% on Thursday following its first-quarter earnings release and the announcement of ...

Several secretive and well-funded biotechs are sharing the first glimpses of data from a new suite of gene editing tools that ...

Maze Therapeutics has found a new buyer for its Pompe disease candidate, five months after scrutiny from the Federal Trade ...

As the head of the trade group BIO and a parent to children with a rare disease, John Crowley is personally and ...

An advisory committee will convene November 14 and 15 to vote on whether Duchenne muscular dystrophy should be included in a ...

Takeda is shuttering its San Diego research site, the company confirmed to Endpoints News. The company told employees on ...

In the lead-up to the likely approval of Geron’s drug to treat certain types of anemia, drug pricing watchdog the Institute ...

Verona Pharma has secured up to $650 million to aid the potential launch of its COPD candidate ensifentrine. Under new ...

Charles River Laboratories’ manufacturing arm delivered a large revenue jump in the first quarter of the year owing to an ...

CytomX and Amgen’s T cell engager showed mixed efficacy signals in an early trial in advanced solid tumors, sending the ...